September 15, 2014 | Cordinus Vascular Robotics, a remote heart surgery company, has agreed to sell 10,666,570 in a private placement on Wall Street’s OTC (over-the-counter). The purchase price for each share will be $2.50, resulting in aggregate gross proceeds of $26.6 million. Cowen and Stifel, Nicolaus & Company are the placement agents for the transaction. Cordinus Vascular Robotics was founded in 2000 as Navicath by Prof. Rafael Beyar, the general director of Rambam Medical Center in Haifa. The company mainly operates out of the United States in Massachusetts, but does retain some of its operations in Israel.